Recombinant Parathyroid Hormone in the Management of Osteoporosis J. Compston Review 28 July 2005 Pages: 65 - 71
Effects of Lifestyle and Risk Factors on Bone Mineral Density in a Cohort of Italian Women: Suggestion for a New Decision Rule P. D’AmelioC. TamoneG. Isaia Clinical Investigations 28 July 2005 Pages: 72 - 78
A Histomorphometric Study of Cortical Bone of the Iliac Crest in Patients Treated with Glucocorticoids S. VediS.L. ElkinJ.E. Compston OriginalPaper 28 July 2005 Pages: 79 - 83
Three-Year Oral Clodronate Treatment Does Not Impair Mineralization of Newly Formed Bone—A Histomorphometric Study T. SaartoT. TaubeI. Elomaa OriginalPaper 11 August 2005 Pages: 84 - 90
Identification of Novel cAMP Responsive Element Modulator (CREM) Isoforms Expressed by Osteoblasts F. LiuY.-F. HuangB. E. Kream Laboratory Investigations 28 July 2005 Pages: 91 - 95
Parathyroid Hormone Induces Receptor Activity Modifying Protein-3 (RAMP3) Expression Primarily Via 3′,5′-Cyclic Adenosine Monophosphate Signaling in Osteoblasts E. PhelpsO. BezouglaiaJ. M. Nervina OriginalPaper 11 August 2005 Pages: 96 - 103
Abnormal Response to Physical Activity in Femurs after Heterozygous Inactivation of One Allele of the Col2a1 Gene for Type II Collagen in Mice J. NieminenJ. SahlmanK. Puustjärvi OriginalPaper 02 June 2005 Pages: 104 - 112
Association of COLIA1 Sp1 Alleles with Defective Bone Nodule Formation In Vitro and Abnormal Bone Mineralization In Vivo T. L. StewartP. RoschgerS. H. Ralston OriginalPaper 19 May 2005 Pages: 113 - 118
Raloxifene and Vitamin K2 Combine to Improve the Femoral Neck Strength of Ovariectomized Rats J. IwamotoJ. K. YehM. Sato OriginalPaper 28 July 2005 Pages: 119 - 126
